Evidence map›Paper›PMID 37220079›Full record

ArticleAccounts of chemical research2023

Structure Elucidation of Secondary Metabolites: Current Frontiers and Lingering Pitfalls.

Mikaela DiBello, Alan R Healy, Herman Nikolayevskiy, Zhi Xu, Seth B Herzon

Open access · greenAbstract read
In one paragraph

Article in Accounts of chemical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mikaela DiBelloDepartment of Chemistry, Yale University, New Haven, Connecticut 06520, United States.ORCID 0000-0002-0948-5863
Alan R HealyDepartment of Chemistry, Yale University, New Haven, Connecticut 06520, United States.ORCID 0000-0002-1231-8353
Herman NikolayevskiyDepartment of Chemistry, Yale University, New Haven, Connecticut 06520, United States.ORCID 0000-0002-4658-4182
Zhi XuDepartment of Chemistry, Yale University, New Haven, Connecticut 06520, United States.ORCID 0000-0002-1476-1367
Seth B HerzonDepartment of Chemistry, Yale University, New Haven, Connecticut 06520, United States.ORCID 0000-0001-5940-9853
Yale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Structural and functional studies of colibactinR01CA215553 · NCI · YALE UNIVERSITY · PI Seth B. Herzon, Christian Jobin · 2018 to 2026
$5.5M
Synthetic and translational studies of antitumor and antimicrobial natural products.R35GM131913 · NIGMS · YALE UNIVERSITY · PI Seth B. Herzon · 2019 to 2026
$4.7M
Synthesis and Study of Complex Antiproliferative and Antimalarial Natural ProductsR01GM110506 · NIGMS · YALE UNIVERSITY · PI HERZON, SETH B. · 2015 to 2018
$1.2M
NCATS NIH HHS UL1 TR001863NCI NIH HHS R01 CA215553NIGMS NIH HHS R01 GM110506NIGMS NIH HHS R35 GM131913
6 · The paper itself

Abstract

Analytical methods allow for the structure determination of submilligram quantities of complex secondary metabolites. This has been driven in large part by advances in NMR spectroscopic capabilities, including access to high-field magnets equipped with cryogenic probes. Experimental NMR spectroscopy may now be complemented by remarkably accurate carbon-13 NMR calculations using state-of-the-art DFT software packages. Additionally, microED analysis stands to have a profound effect on structure elucidation by providing X-ray-like images of microcrystalline samples of analytes. Nonetheless, lingering pitfalls in structure elucidation remain, particularly for isolates that are unstable or highly oxidized. In this Account, we discuss three projects from our laboratory that highlight nonoverlapping challenges to the field, with implications for chemical, synthetic, and mechanism of action studies. We first discuss the lomaiviticins, complex unsaturated polyketide natural products disclosed in 2001. The original structures were derived from NMR, HRMS, UV-vis, and IR analysis. Owing to the synthetic challenges presented by their structures and the absence of X-ray crystallographic data, the structure assignments remained untested for nearly two decades. In 2021, the Nelson group at Caltech carried out microED analysis of (-)-lomaiviticin C, leading to the startling discovery that the original structure assignment of the lomaiviticins was incorrect. Acquisition of higher-field (800 MHz

Indexed as

Biological ProductsPolyketidesCarbon IsotopesPeptidesBiological ProductsCarbon-13Carbon IsotopescolibactinPeptidesPolyketides

Identifiers

PMID37220079
PMCPMC10468810
OpenAlexW4377819634

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.